# Cell cycle dysregulation in cancer

*PRI Rank #9 · Topics and Trends in Most Cited Cancer-related Molecular Pathways Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/cancer-related-molecular-pathways/2026/rank-9*

| Field | Value |
| --- | --- |
| Rank | #9 |
| 18m citations | 65 |
| Journal | Pharmacological Reviews |
| Year | 2024 |
| DOI | 10.1016/j.pharmr.2024.100030 |
| Corresponding authors | Antonino Glaviano |
| Institution | University of Palermo, Italy |

**Ranking page:** [Topics and Trends in Most Cited Cancer-related Molecular Pathways Papers, Class of 2026](https://pri.pepkio.com/top-papers/cancer-related-molecular-pathways/2026)

**Paper link:** [10.1016/j.pharmr.2024.100030](https://doi.org/10.1016/j.pharmr.2024.100030)

## Topics

cell cycle dysregulation · cancer · cyclins · cyclin-dependent kinase · CDK inhibitor · checkpoint control · G1/S transition · G2/M transition · p53 pathway · Rb-E2F pathway · oncogenes · tumor suppressor · cell cycle progression · Mitotic checkpoint · DNA damage response

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Cancer-related Molecular Pathways Papers, Class of 2026. https://pri.pepkio.com/top-papers/cancer-related-molecular-pathways/2026. Accessed 2026-10-28.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```